Projects per year
Personal profile
Research Strategic Pillar
The Chief Research Officer, has determined that UTMB research should be prioritized into six health communities. This researcher has received the following badge(s):
Research Strategic Pillar Keywords
- Infectious/ Immunological Health
Fingerprint
Dive into the research topics where Thomas Geisbert is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Rapid Ecosystem for Agnostic Antibody DiscoverY (REAADY)
Geisbert, T. (PI)
Vanderbilt University Medical Center ( Award #W911SR2390017)
1/18/25 → 8/17/25
Project: Research project
-
Genetic and Structural Basis for Virus Neutralization
Geisbert, T. (PI)
Vanderbilt University Medical Center ( Award #75N9302400072)
9/16/24 → 9/15/25
Project: Research project
-
Human Nanobides as Hantavirus Countermeasures
Geisbert, T. (PI)
Henry M. Jackson Foundation for the Advancement of Military Medicine ( Award #HU00012420061)
8/15/24 → 8/14/26
Project: Research project
-
ML-enabled design of prototype pathogen vaccines and therapeutics
Geisbert, T. (PI)
University of Washington ( Award #1U19AI18188101)
8/12/24 → 7/31/25
Project: Research project
-
Paramyxoviridae and Bunyavirales Vaccines and Antibodies Center (PABVAX)
Geisbert, T. (PI)
National Institute of Allergy and Infectious Diseases ( Award #1U19AI18193001)
7/30/24 → 6/30/27
Project: Research project
-
Evaluation of Vaccines and Therapeutics Against Marburg Virus in Nonhuman Primate Models
Woolsey, C., Geisbert, T. W. & Cross, R. W., 2025, Methods in Molecular Biology. Humana Press Inc., p. 297-315 19 p. (Methods in Molecular Biology; vol. 2877).Research output: Chapter in Book/Report/Conference proceeding › Chapter
-
Mapping the antibody response to Lassa virus vaccination of non-human primates
Enriquez, A. S., Avalos, R. D., Parekh, D., Cooper, C. L., Morrow, G., Geisbert, T. W., Parks, C. L., Hastie, K. M. & Saphire, E. O., Apr 2025, In: EBioMedicine. 114, 105673.Research output: Contribution to journal › Article › peer-review
Open Access -
Oral obeldesivir provides postexposure protection against Marburg virus in nonhuman primates
Cross, R. W., Woolsey, C., Prasad, A. N., Borisevich, V., Agans, K. N., Deer, D. J., Harrison, M. B., Dobias, N. S., Fenton, K. A., Cihlar, T., Nguyen, A. Q., Babusis, D., Bannister, R., Vermillion, M. S., Chu, V. C. & Geisbert, T. W., 2025, (Accepted/In press) In: Nature Medicine. 1083429.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
The oral drug obeldesivir protects nonhuman primates against lethal Ebola virus infection
Woolsey, C., Cross, R., Chu, V. C., Prasad, A., Agans, K. N., Borisevich, V., Deer, D. J., Harrison, M. B., Martinez, J. K., Dobias, N. S., Fenton, K., Cihlar, T., Nguyen, A. Q., Babusis, D., Bannister, R., Vermillion, M. S. & Geisbert, T. W., Mar 14 2025, In: Science Advances. 11, 11, eadw0659.Research output: Contribution to journal › Article › peer-review
Open Access -
A Glass-Half-Full Perspective on Negative Data in Ebolavirus Vaccine Studies
Prasad, A. N. & Geisbert, T. W., Nov 15 2024, In: Journal of Infectious Diseases. 230, 5, p. 1057-1060 4 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access
Press/Media
-
Here’s what’s happening with the Marburg virus outbreak in Rwanda
10/9/24
1 item of Media coverage
Press/Media: Expert Comment